000026301 000__ 01281cam\a2200421\i\4500 000026301 001__ 26301 000026301 003__ SzGeWIPO 000026301 005__ 20240708162401.0 000026301 008__ 071205s2010 enk|||||r|||| 00| 0 por d 000026301 035__ $$a(wipo)0 000026301 035__ $$a(OCoLC)1159949290 000026301 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000026301 041__ $$aeng 000026301 043__ $$ae-pl--- 000026301 050_4 $$aK1401.A15$$bJ675 000026301 08204 $$a346.048$$222 000026301 084__ $$aGB 137 000026301 1001_ $$aOzog, M. 000026301 24510 $$aPharmaceutical trade mark practice in Poland. 000026301 264_1 $$aOxford [England] :$$bOxford University Press,$$c2010. 000026301 300__ $$a1 volume ([8] pages) ;$$c[28] cm. 000026301 336__ $$atext$$btxt$$2rdacontent 000026301 337__ $$aunmediated$$bn$$2rdamedia 000026301 338__ $$avolume$$bnc$$2rdacarrier 000026301 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1532 ;$$vGB 137 Nov 2010 Vol 5 No 11, pages 770-777 000026301 650_0 $$aIntangible property. 000026301 650_0 $$aIntellectual property. 000026301 650_0 $$aIntellectual property$$zPoland. 000026301 650_4 $$aIP litigation 000026301 650_4 $$aTrademarks$$zPoland 000026301 650_4 $$aDrugs$$xPharmaceutical industry 000026301 651_0 $$aPoland$$xCommerce$$xLaw and legislation. 000026301 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$vGB 137 Nov 2010 Vol 5 No 11, pages 770-777. 000026301 8564_ $$uhttp://dx.doi.org/10.1093/jiplp/jpq127$$y[For WIPO staff only] 000026301 903__ $$aJournal of Intellectual Property Law & Practice. 000026301 904__ $$aJournal article 000026301 942__ $$cART$$jGB 137 Nov 2010 Vol 5 No 11$$2ddc 000026301 952__ $$w2011-01-20$$p2011-0074$$u40547$$bMAIN$$10$$kGB 137$$v2011-01-20$$70$$cMain library$$yART 000026301 980__ $$aBIB 000026301 999__ $$c28692$$d28692